At a Glance
Dosage
Only in 25I-NBOH
sublingual
| Level | Dose |
|---|---|
| Threshold | 50 µg |
| Light | 200–500 µg |
| Common | 500–900 µg |
| Strong | 900–1400 µg |
Only in 1cP-LSD
oral
| Level | Dose |
|---|---|
| Threshold | 15 µg |
| Light | 25–75 µg |
| Common | 75–150 µg |
| Strong | 150–300 µg |
| Heavy |
Duration
Only in 25I-NBOH
sublingual
Afterglow
Onset: 15 min – 1 hrsCome Up: 30 min – 1.5 hrsPeak: 2 hrs – 3.5 hrsOffset: 1.5 hrs – 2.5 hrsAfterglow: 72 hrs – 288 hrs
Total: 5 hrs – 8 hrs
Only in 1cP-LSD
oral
Peak
Effects
Safety
Interaction: 25I-NBOH + 1cP-LSD
No direct interaction data available between these substances. This does not mean the combination is safe.
25I-NBOH — Dangerous Interactions
No dangerous interactions recorded.
1cP-LSD — Dangerous Interactions
No dangerous interactions recorded.
Frequently Asked Questions
What is the difference between 25I-NBOH and 1cP-LSD?
25I-NBOH is classified as a Psychedelic (Substituted phenethylamines) while 1cP-LSD is classified as a Psychedelic (Lysergamides). They share 46 effects in common, with 12 effects unique to 25I-NBOH and 10 unique to 1cP-LSD.
Is it safe to combine 25I-NBOH and 1cP-LSD?
There is no direct interaction data available for combining 25I-NBOH and 1cP-LSD. This does not mean the combination is safe. Always exercise caution and research thoroughly.
Which is stronger, 25I-NBOH or 1cP-LSD?
25I-NBOH and 1cP-LSD are typically administered via different routes, making a direct potency comparison difficult. They belong to different pharmacological profiles and should not be compared by dose alone.